View Patent Application Here
Piper Sandler Maintains Overweight on Albemarle, Raises Price Target to $330
Piper Sandler analyst Charles Neivert maintains Albemarle (NYSE:ALB) with a Overweight and raises the price target from $310 to $330.
Related Posts
ConocoPhillips Q4 EPS $2.71 Misses $2.81 Estimate, Sales $19.26B Beat $18.03B Estimate
ConocoPhillips (NYSE:COP) reported quarterly earnings of $2.71 per share which missed the analyst consensus estimate of $2.81 by 3.56 percent. This is a 19.38 percent increase over earnings of $2.27 per share from the
Nemaura Medical Late Friday Reported Q3 EPS $(0.15) Misses $(0.14) Estimate, Sales $183.63K Beat $150.00K Estimate
Nemaura Medical (NASDAQ:NMRD) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 150 percent decrease over losses of $(0.06) per share from
Morgan Stanley Maintains Equal-Weight on Ecolab, Lowers Price Target to $200
Morgan Stanley maintains Ecolab (NYSE:ECL) with a Equal-Weight and lowers the price target from $240 to $200.